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Available online 13 September 2016Background: Public trust in immunization is an increasingly important global health issue. Losses in conﬁdence in
vaccines and immunization programmes can lead to vaccine reluctance and refusal, risking disease outbreaks
and challenging immunization goals in high- and low-income settings. National and international immunization
stakeholders have called for better monitoring of vaccine conﬁdence to identify emerging concerns before they
evolve into vaccine conﬁdence crises.
Methods:We perform a large-scale, data-driven study on worldwide attitudes to immunizations. This survey –
which we believe represents the largest survey on conﬁdence in immunization to date – examines perceptions
of vaccine importance, safety, effectiveness, and religious compatibility among 65,819 individuals across 67
countries. Hierarchical models are employed to probe relationships between individual- and country-level
socio-economic factors and vaccine attitudes obtained through the four-question, Likert-scale survey.
Findings: Overall sentiment towards vaccinations is positive across all 67 countries, however there is wide vari-
ability between countries and across world regions. Vaccine-safety related sentiment is particularly negative in
the European region, which has seven of the ten least conﬁdent countries, with 41% of respondents in France
and 36% of respondents in Bosnia & Herzegovina reporting that they disagree that vaccines are safe (compared
to a global average of 13%). The oldest age group (65+) and Roman Catholics (amongst all faiths surveyed)
are associated with positive views on vaccine sentiment, while the Western Paciﬁc region reported the highest
level of religious incompatibility with vaccines. Countries with high levels of schooling and good access to health
services are associated with lower rates of positive sentiment, pointing to an emerging inverse relationship be-
tween vaccine sentiments and socio-economic status.
Conclusions: Regular monitoring of vaccine attitudes – coupled with monitoring of local immunization rates – at
the national and sub-national levels can identify populations with declining conﬁdence and acceptance. These
populations should be prioritized to further investigate the drivers of negative sentiment and to inform appropri-
ate interventions to prevent adverse public health outcomes.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
Vaccine conﬁdence
Vaccine safety
Attitudes
Global immunization
Hierarchical regressionology and Population Health,
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. This is an open access article under1. Introduction
Vaccine conﬁdence is an increasingly important global public health
issue,with decreases in conﬁdence leading towell-documented cases of
disease outbreaks, setbacks to global polio eradication as well as other
immunization goals, and contentious political debates in high and
low-income countries alike (Brown et al., 2010; Hanley et al., 2015;the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
296 H.J. Larson et al. / EBioMedicine 12 (2016) 295–301Khetsuriani et al., 2010; Larson et al., 2011; Yu et al., 2016). The World
Health Organization's (WHO) Strategic Advisory Group of Experts
(SAGE) on Immunization (WHO, 2014) as well as national immuniza-
tion programmes (US Dept. Health and Human Services, 2015) have
called for better monitoring of vaccine conﬁdence and hesitancy to
inform the development of communication and other interventions to
address conﬁdence gaps, to sustain conﬁdence in vaccines and immuni-
zation programmes and to avert conﬁdence crises and their public
health consequences.
In March 2012, the SAGEWorking Group on Vaccine Hesitancy con-
vened to deﬁne “vaccine hesitancy” and to develop and standardize sur-
vey frameworks within which the scale and determinants of vaccine
hesitancy and vaccine conﬁdence can be measured (Larson et al.,
2015a, 2015b). A number of studies have since investigated attitudes to-
wards vaccines in diverse contexts, including investigation of attitudes
towards immunization programmes (Dubé et al., 2016), vaccine hesi-
tancy among general practitioners (GPs) (Verger et al., 2015), the detri-
mental effects of non-voluntary immunization campaigns (especially
amongst those already expressing negative vaccine sentiment)
(Betsch and Böhm, 2016), and social-network analyses identifying clus-
tering of vaccine-refusing households (Onnela et al., 2016).
This latter study is particularly important in the context of vaccine re-
fusal, since it supports a growing body of research which underscores
the role of clusters of non-vaccinators in lowering herd immunity and
allowing for disease outbreaks (Salathé and Bonhoeffer, 2008; Liu et al.,
2015). The US Centers for Disease Control have also recognized this phe-
nomenon, highlighting also the vulnerability of under-vaccinated groups
to imported diseases, and noting a paradigm-shift away from access as
the primary barrier to vaccinations and towards “philosophical objections”
(CDC, 2013). It is thus worth stressing the importance of identifying and
monitoring hesitant groups: small clusters of non-vaccinators can have
disproportionately adverse effects onherd immunity andepidemic spread.
Our objectives in this paper are to: respond to international calls for
monitoring public conﬁdence in immunization; examine worldwide
variation in attitudes, exploring the socio-economic determinants of
vaccine attitudes; and, ﬁnally, interpret and discuss the results in the
context of global immunization and monitoring systems. This study –
in collaboration with WIN/Gallup International Associationi – draws
from the ten-question Likert survey proposed by SAGE (Larson et al.,
2015a, 2015b) and comprises survey responses from 65,819 individuals
across 67 countries to questions on vaccination importance, safety, ef-
fectiveness, and religious compatibility. This study builds on a ﬁve-
country vaccine conﬁdence survey conducted in collaboration with
Win/Gallup International in 2014 (Larson et al., 2014a, 2014b). We be-
lieve this study to be of unprecedented scale in the vaccine conﬁdence
literature, and a potential cornerstone for monitoring of public conﬁ-
dence in immunization. We begin by exploring worldwide variation in
attitudes to four statements investigating individuals' perceptions of
the importance, safety, and effectiveness of vaccines, aswell as the com-
patibility with their religious beliefs. We then highlight regional trends
in vaccine safety perceptions and explore socio-economic determinants
of vaccine sentiments using logistic hierarchical modelling.2. Methods
2.1. Data
Individual-level vaccine-sentiment and socio-economic data in this
study was collected through a WIN/Gallup International Associationi Disclaimer: Gallup International Association or its members are not related to Gallup
Inc., headquartered inWashingtonD.Cwhich is no longer amember ofGallup Internation-
al Association. Gallup International Association does not accept responsibility for opinion
polling other than its own.We require that our surveys be credited fully as Gallup Interna-
tional (not Gallup or Gallup Poll).For further details see website: www.Gallup-
international.com.survey. The WIN/GIA Annual Survey has been conducted annually
since 1977. In 2015, in collaboration with the Vaccine Conﬁdence Pro-
ject at the London School of Hygiene & Tropical Medicine,ii WIN-Gallup
International extended their annual 14-question survey conducted in
67 countries to include four questions related to attitudes towards vac-
cines. A total of 65,819 personswere interviewed globally,iii with a sam-
ple of around 500men and 500 women interviewed either face-to-face
(28 countries, n=30,230), via telephone (16 countries, n=13,062), or
online (23 countries, n= 22,527). Algeria reported the fewest respon-
dents (398), whilst Afghanistan reported the most (2080). The ﬁeld-
work was conducted between September 2015 and December 2015.
The interviewmethod selected in each country was largely determined
by the availability of the internet and the phone. In those countries
where the internet is widely used (e.g. Europe) the majority of ﬁeld-
work was carried out via online panels. In those countries where
phone penetration is sufﬁciently high a random digit dial telephone
methodology was used. In those countries with poor internet and land-
line phone coverage (e.g. Pakistan) interviews were carried out face-to-
face following a multi stage random probability methodology. In each
country only one mode of interviewing was used.
Each respondent was asked to rate – on the ﬁve-point Likert
scale: strongly agree, tend to agree, do not know, tend to disagree,
strongly disagree – the extent to which they agreed with four
statements pertaining to vaccination: “vaccines are important for
children to have”; “overall I think vaccines are safe”; “overall I
think vaccines are effective”; and “vaccines are compatible with my
religious beliefs”. In addition to these survey responses, individual
respondents' sex, age, income level, religion, work status, and
educational level were recorded. The overall missing data fraction
is 6.4%, however, this varies substantially by country and covariate:
sex, age, work status, and education have ~1% missing data, whereas
religion and income have ~11% missing values. Missing responses
are present within the question response data though their
prevalence is difﬁcult to establish since “no response” and “do not
know” are coded collectively. The number of “do not know/no
response” to each of the four questions is 3%, 5%, 4%, and 12%
respectively, suggesting 3% as a likely upper threshold for those
providing no response.
To allow the statistical investigation into socio-economic factors
that affect country-wide variation in response data, country-level
data was also collected from a variety of sources including the
World Health Organization, the World Bank, and the United Nations
Development Programme. This set of socio-economic factors –which
includes GDP, births attended by skilled health staff, child mortality,
access to sanitation, access to water, total health spending, andmean
years in school – allows variation of country-level variables with
response to be investigated in addition to the individual-level
factors.2.2. Statistical Analysis
A hierarchical logistic model is used to probe the ties between
individual- and country-level variables and attitudes to vaccines. The
responses to each question are dichotomized into positive versus non-
positive (including don't know or no response), with partial pooling
between countries via a combination of random effects and regression
on country level factors. There are a total of 18 missing data points
(out of a total of 469) for the country-level factors, which are imputed
using mean-imputation. Odds ratios (with 95% conﬁdence intervals)
are derived for risk factors. Full details of the model are provided in
the Supplementary materials. R 3.3.0 is used for all analyses and
stargazer is used to create Table 1 (R, 2016; Hlavac, 2013).ii www.vaccineconﬁdence.org
iii http://www.wingia.com/web/ﬁles/richeditor/ﬁlemanager/Methosheet_Global.pdf
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Immunization-response data is renormalized after removing “donot
know/no response” responses. An overall summary by question and
country (stratiﬁed by world region as deﬁned by the World Health
Organization) is shown in Fig. 1 using weighted responses, which are
adjustments to account for over- or under-represented individuals
within the population. (World regions are categorized by WHO region
according to the deﬁnitions at www.who.int/about/regions/en
(accessed 08/07/2016): AFR (Africa region); AMR (Americas region);
EMR (Eastern Mediterranean region); EUR (European region); SEAR
(South-East Asia region); and WPR (Western Paciﬁc region).) Overall
differences in responses between the six WHO regions are again
shown as Likert responses in Fig. 2A and worldwide vaccine attitudes
to vaccine safety are mapped in Fig. 2C (South, 2011).
Variability in vaccine sentiment across countries and WHO regions is
investigated by considering the fraction of respondents who either
agree or disagree with the four statements on immunization (Fig. 1).
The EUR region reports the highest mean-averaged (across all countries
in the region) negative responses for vaccine importance, safety, and ef-
fectiveness (8.0%, 17.0%, and 11.3%, respectively) and seven of the ten
most negatively-reporting countries to vaccine safety are in EUR. Pairwise
t-tests between regional means demonstrate that EUR has moreVaccines are important 
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SEAR and WPR report the most religious incompatibility (25.7% and
24.3% respectively): pairwise t-tests reveal signiﬁcance at p= 0.05 be-
tween these two regions and the four others, but none between them.
In Fig. 1, countries are ranked by the percentage of (normalized)
negative sentiment expressed towards a given question. (All ﬁgures
quoted are normalized responses.) Respondents from Bangladesh
(0.3%), Ecuador (0.4%), and Iran (0.5%) report the lowest levels of im-
portance-related skepticism, whilst respondents from Russia (17.1%),
Azerbaijan (15.7%), and Italy (15.4%) report the highest (the global av-
erage is 5.8%). With regard to vaccine safety, Bangladesh (0.2%), Saudi
Arabia (1.2%), and Argentina (1.3%) report the lowest levels of skepti-
cism, whilst respondents from France (45.2%), Bosnia & Herzegovina
(38.3%), and Japan (31.0%) have the highest (the global average is
13.0%). Argentina (1.3%), Ethiopia (2.1%), and Ecuador (2.2%) have the
lowest levels of effectiveness-related doubts, whilst Bosnia & Herzego-
vina (27.3%), Russia (20.1%), and Italy (18.7%) have the highest (global
average 9.1%). With regard to religious compatibility, Saudi Arabia
(2.3%), Finland (2.6%), and Brazil (3.2%) have the lowest levels of report-
ed incompatibility, whilst Mongolia (50.5%), Thailand (44.4%), and
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Fig. 2.Vaccine conﬁdence byworld region and differences between perceived safety and importance. (A) Summary of Likert Responses byworld region. (B) Pearson correlations between
percentage of respondents across all countries agreeing ("strongly agree" or "tend to agree") with each statement. (C) Vaccine World map of percentage negative ("tend to disagree" or
"strongly agree") survey responses to the statement "overall I think vaccines are safe". (D) Differences in the proportion of people responding that they believe vaccines are important but
unsafe (with 95% conﬁdence intervals).
298 H.J. Larson et al. / EBioMedicine 12 (2016) 295–301In EUR, vaccine safety and importance are concerns, though there is
relatively little reported religious incompatibility. In WPR, however,
great concerns are expressed about safety, importance, and religious com-
patibility (Fig. 2A). Pearson correlations between the fractions of negative
responses (across countries) between questions reveals that responses
are more consistent among vaccine importance, safety, and effectiveness
thanwith religious compatibility (Fig. 2B). A notable trend is the observa-
tion that the number of respondentswho reportmore positive sentiment
for vaccine importance is larger than that for vaccine safety. The striking
consistency in this trend across most of the countries surveyed is clear
in Fig. 2C. This suggests that vaccination intent could be buffered by per-
ceived importance, suggesting that people are willing to take a risk given
an effective guard against disease. As suggested by the correlation in re-
sponses of vaccine importance and vaccine safety, individual responses
between vaccine effectiveness and vaccine safety are very similar (see
Supplementary material), though we note a higher fraction of countries
with no signiﬁcant difference and some countries with a higher fraction
of respondents reporting that vaccines are safe then effective (Nigeria,
Ghana, Pakistan, Indonesia, and Bangladesh).
Worldwide levels of vaccine-safety skepticismaremapped in Fig. 2C.
With the notable exceptions of France and Italy –whichhave high levels
of safety-based vaccine skepticism – Western and Northern European
countries express less concern about vaccine safety than Eastern and
Southern European countries. Spatial contiguity is not limited to
Europe: USA, Canada, and Mexico have higher levels of safety concerns
than countries in South America; and China, Mongolia, Japan, Hong
Kong, and Vietnam all have high fractions of negative responses.
Results of the logistic hierarchicalmodel employed to investigate the
link between both individual- and country-level predictors, and atti-
tudes towards immunizations are shown in Table 1. To compare dataon different scales, country-level factors have been z-scored so that a
unit increase in country-level factor is associated with the reported
odds ratios. Parameters with p-values lower than 0.05 are considered.
Males are less likely to think vaccines are important than females
(odds ratio [OR] 0.86, 95% conﬁdence interval [CI] 0.80 to 0.94), but
there are no signiﬁcant differences between the sexes for vaccine safety,
effectiveness, or religious compatibility. Those aged 25–34 are less likely
to believe vaccines are safe compared to 18–24 year olds (OR 0.88, CI
0.77–1.00); over 65 s are bothmore likely to report that vaccines are ef-
fective (OR 1.39, CI 1.11–1.76) and to express religious incompatibilities
(OR 1.27, CI 1.05–1.53). Any level of education elevates positive views
towards immunizations for vaccine importance, effectiveness, and reli-
gious compatibility; yet, notably, not for vaccine safety. Masters/PhD –
the highest educational level – is not associated with more positive
views on vaccine importance and effectiveness than those with no edu-
cation. The ﬁfth income quintile is associated with less positive vaccine
sentiment across all four statements than higher income bands. Those
unemployed are more likely to hold negative sentiment for vaccine
safety (OR 0.77, CI 0.67–0.90) and effectiveness (OR 0.79, CI 0.67–
0.92) than the baseline group. Compared to Roman Catholics, religious
groups – including atheists/agnostics and with possible exceptions of
Hindus and Jews – are less likely to hold positive vaccine sentiment
for vaccine importance and vaccine safety. Other Christians and athe-
ists/agnostics are more likely to have religious compatibility issues;
however, it should be noted that it is unclearwhether atheists/agnostics
could have reasonably answered this question, since the phrasing as-
sumed that the respondent's religiosity.
For vaccine importance, countries with higher levels of births
attended by skilled health staff (OR 0.66, CI 0.49–0.88) and schooling
(OR 0.56, CI 0.43–0.72) are associated with less positive responses,
Table 1
Results of the logistic hierarchical regression.
Odds ratios and 95% conﬁdence intervals for theﬁxed effects in the logistic hierarchicalmodel (see Supplementarymaterials). Survey responses are dichotomized so that odds ratios great-
er than one (for example) represent an association between explanatory variable and positive vaccine sentiment. Males are less likely to think vaccines are important than females. Any
level of education elevates pro-vaccine views for importance, efﬁcacy, and religious compatibility but not for vaccine safety. Over 65 s are both more likely to report that vaccines are ef-
fective (OR 1.39, CI 1.11–1.76) and to express religious incompatibilities. Countries with higher levels of education and a higher fraction of births attended by skilled health staff are as-
sociated with decreased odds of pro-vaccination attitudes.
Importance Safety Effectiveness Religious compatibility
Individual-level
Sex
female (baseline)
male 0.86 (0.80–0.94)⁎⁎⁎ 1.01 (0.94–1.09) 0.96 (0.89–1.03) 0.96 (0.90–1.02)
Age
18–24 (baseline)
25–34 0.89 (0.77–1.04) 0.88 (0.77–1.00)⁎⁎ 0.97 (0.86–1.10) 0.94 (0.85–1.05)
35–44 0.99 (0.84–1.17) 0.95 (0.83–1.07) 1.02 (0.89–1.16) 1.06 (0.94–1.20)
45–54 0.99 (0.83–1.19) 0.97 (0.85–1.12) 1.16 (1.00–1.34)* 1.05 (0.93–1.20)
55–64 0.99 (0.80–1.23) 0.98 (0.84–1.13) 1.07 (0.90–1.28) 1.14 (0.98–1.32)⁎
65+ 0.94 (0.69–1.27) 1.07 (0.88–1.31) 1.39 (1.11–1.76)⁎⁎⁎ 1.27 (1.05–1.53)⁎⁎
Education
No education (baseline)
Primary 1.46 (1.08–1.97)⁎⁎ 0.90 (0.71–1.15) 1.20 (0.99–1.46)* 1.12 (0.94–1.35)
Secondary 1.39 (1.05–1.83)⁎⁎ 0.95 (0.74–1.22) 1.31 (1.08–1.57)⁎⁎⁎ 1.19 (0.97–1.44)⁎
University 1.44 (1.09–1.92)⁎⁎ 0.98 (0.76–1.26) 1.39 (1.15–1.68)⁎⁎⁎ 1.35 (1.08–1.68)⁎⁎⁎
Masters/PhD 1.33 (0.94–1.89) 0.98 (0.73–1.33) 1.33 (1.05–1.70)⁎⁎ 1.43 (1.12–1.83)⁎⁎⁎
Income
First quintile (low) (baseline)
Second quintile 1.19 (1.04–1.38)⁎⁎ 1.17 (1.04–1.31)⁎⁎⁎ 1.21 (1.07–1.36)⁎⁎⁎ 1.08 (0.98–1.20)
Third quintile 1.36 (1.16–1.58)⁎⁎⁎ 1.25 (1.10–1.43)⁎⁎⁎ 1.31 (1.13–1.50)⁎⁎⁎ 1.16 (1.04–1.29)⁎⁎⁎
Fourth quintile 1.53 (1.26–1.85)⁎⁎⁎ 1.32 (1.15–1.53)⁎⁎⁎ 1.43 (1.22–1.68)⁎⁎⁎ 1.19 (1.05–1.36)⁎⁎⁎
Fifth quintile (high) 1.43 (1.21–1.70)⁎⁎⁎ 1.28 (1.10–1.48)⁎⁎⁎ 1.33 (1.14–1.55)⁎⁎⁎ 1.12 (0.96–1.30)
Work type
Housewife (baseline)
Retired/disabled 1.13 (0.88–1.45) 0.96 (0.81–1.14) 0.91 (0.77–1.08) 1.00 (0.87–1.15)
Student 0.99 (0.77–1.27) 0.96 (0.80–1.15) 1.04 (0.85–1.26) 1.00 (0.86–1.17)
Unemployed 0.95 (0.77–1.17) 0.77 (0.67–0.90)⁎⁎⁎ 0.79 (0.67–0.92)⁎⁎⁎ 0.90 (0.78–1.05)
Part-time 0.86 (0.70–1.07) 0.89 (0.75–1.06) 0.91 (0.77–1.07) 0.91 (0.78–1.06)
Full-time 1.03 (0.86–1.25) 1.01 (0.88–1.16) 1.00 (0.88–1.15) 0.98 (0.87–1.11)
Religion
Roman Catholic (baseline)
Protestant 0.57 (0.43–0.77)⁎⁎⁎ 0.72 (0.58–0.90)⁎⁎⁎ 0.83 (0.67–1.02)⁎ 1.04 (0.85–1.26)
Russian/Eastern-Orth 0.41 (0.30–0.57)⁎⁎⁎ 0.56 (0.46–0.70)⁎⁎⁎ 0.64 (0.51–0.82)⁎⁎⁎ 0.87 (0.71–1.07)
Other Christian 0.52 (0.41–0.67)⁎⁎⁎ 0.74 (0.61–0.90)⁎⁎⁎ 0.72 (0.58–0.89)⁎⁎⁎ 0.81 (0.68–0.97)⁎⁎
Muslim 0.63 (0.43–0.91)⁎⁎ 0.72 (0.55–0.96)⁎⁎ 0.67 (0.51–0.89)⁎⁎⁎ 0.82 (0.62–1.08)
Jewish 1.48 (0.50–4.39) 0.64 (0.34–1.20) 2.43 (0.74–7.98) 0.97 (0.45–2.06)
Buddhist 0.30 (0.17–0.51)⁎⁎⁎ 0.48 (0.32–0.71)⁎⁎⁎ 0.55 (0.35–0.87)⁎⁎ 0.83 (0.55–1.26)
Hindu 0.55 (0.28–1.08)⁎ 1.40 (0.66–2.97) 0.69 (0.41–1.16) 1.07 (0.61–1.88)
Other 0.29 (0.21–0.38)⁎⁎⁎ 0.45 (0.35–0.58)⁎⁎⁎ 0.44 (0.34–0.57)⁎⁎⁎ 0.47 (0.38–0.59)⁎⁎⁎
Atheist/agnostic 0.49 (0.38–0.64)⁎⁎⁎ 0.73 (0.61–0.86)⁎⁎⁎ 0.75 (0.63–0.91)⁎⁎⁎ 0.45 (0.38–0.54)⁎⁎⁎
Country-level
Health expenditure (% of GDP) 0.89 (0.74–1.08) 0.71 (0.60–0.85)⁎⁎⁎ 0.81 (0.70–0.93)⁎⁎⁎ 1.00 (0.87–1.14)
Births attended (% of total) 0.66 (0.49–0.88)⁎⁎⁎ 0.55 (0.44–0.68)⁎⁎⁎ 0.75 (0.62–0.91)⁎⁎⁎ 0.79 (0.65–0.96)⁎⁎
GDP per capita (US$) 1.56 (1.25–1.95)⁎⁎⁎ 1.67 (1.38–2.02)⁎⁎⁎ 1.68 (1.43–1.97)⁎⁎⁎ 0.99 (0.86–1.15)
U5 mort. rate (per 1000 births) 0.76 (0.55–1.06) 0.93 (0.71–1.23) 0.94 (0.75–1.18) 1.16 (0.93–1.45)
Sanitation access (% with access) 0.82 (0.58–1.17) 1.35 (1.00–1.82)⁎⁎ 1.21 (0.96–1.54) 1.29 (1.01–1.65)⁎⁎
Water access (% with access) 1.31 (0.99–1.75)⁎ 1.23 (0.98–1.54)⁎ 0.94 (0.78–1.14) 1.05 (0.88–1.26)
Schooling (years) 0.56 (0.43–0.72)⁎⁎⁎ 0.73 (0.60–0.93)⁎⁎⁎ 0.63 (0.52–0.75)⁎⁎⁎ 0.80 (0.66–0.97)⁎⁎
⁎ p b 0.1.
⁎⁎ p b 0.05.
⁎⁎⁎ p b 0.01.
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sociated with more positive responses. For vaccine safety and effective-
ness, the results are similar, except health expenditure is associated
with negative responses, and sanitation access is associated with posi-
tive responses (for vaccine effectiveness only). Higher levels of births
attended by skilled health staff (OR 0.79, CI 0.65–0.96) and schooling
(OR 0.80, CI 0.66–0.97) are associated with anti-vaccine sentiment for
religious compatibility, whilst higher levels of sanitation access (OR
1.29, CI 1.01–1.65) are associated with pro-vaccine sentiment.
4. Discussion
We have performed a large-scale, data-driven study into worldwide
variations in attitudes to vaccines.We ﬁnd that vaccine safety sentimentis more negative in the European and the Western Paciﬁc regions,
where nine of the ten least conﬁdent countries are located (France,
Bosnia & Herzegovina, Russia, Ukraine, Greece, Armenia, Slovenia,
Japan, and Mongolia). Conversely, vaccines are perceived to be safe
across countries surveyed in the South East Asian region (Bangladesh,
Indonesia, Thailand, and India). The more negative vaccine-safety per-
ceptions in the European region is striking, particularly given wide-
spread access to vaccines. Our research thus stresses the emerging
shift away from access to vaccines as the primary barrier to vaccination
in many countries, a ﬁnding supported by other European studies, such
as a recent reviewwhich ﬁnds vaccine side-effects and vaccine safety as
themost commonly-cited reservation amongst the public (Yaqub et al.,
2014). The extreme negative sentiment around vaccine safety reported
in France builds upon multiple strands of vaccine controversies and
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clude controversies relating to side effects of the hepatitis B vaccine
(Marshall, 1998); physician-led petitions disputing the hexavalent vac-
cine for infants and theHPV vaccine (Collange et al., 2016); and hesitan-
cy amongst general practitioners with nearly one in four GPs
responding that some vaccines recommended by the French public
health authorities are not useful (Verger et al., 2015), and many
reporting doubt in immunization programmes (Raude et al., 2016). Al-
though the highest levels of vaccine skepticism were reported in Eu-
rope, the longer term global impacts should not be underestimated as
reported in separate research on transnational inﬂuences of vaccine
sentiment (Larson et al., 2014a, 2014b).
We ﬁnd that a larger proportion of respondents report more posi-
tively on vaccine importance than vaccine safety, suggesting that per-
ceptions of vaccine importance may mitigate losses in vaccination
uptake (with similar results for the difference between vaccine effec-
tiveness and vaccine safety, though noticeable exceptions for Nigeria,
Ghana, Pakistan, Indonesia, and Bangladesh – see Supplementarymate-
rial).Many countries are found to have strong faith-compatibility issues,
most notably in Thailand and Mongolia. In addition to investigating the
relationship between vaccine importance, vaccine safety and vaccina-
tion intent, there is also a pressing need to clarify the vaccination intent
of individuals who think that vaccines are incompatible with their faith.
Religious fundamentalism has been cited as a major factor of polio re-
fusal in Afghanistan, Nigeria, and Pakistan (Ahmed et al., 2013;
Warraich, 2009) which have moderate religious objection rates within
the Muslims sampled (3%, 12% and 14% respectively); however, faith
type alone is not linked to vaccination issues and interacts with other
national factors: Saudi Arabia – a country with 100% Muslim respon-
dents – has a very low religious objection rate (2%). As Grabenstein
notes in a review of religious teachings and vaccination (Grabenstein,
2013), there are few religious groups, with the exception of Christian
Scientists, whose ofﬁcial religious texts explicitly reject immunization.
Grabenstein's review found that most vaccine reluctance and refusal,
sometimes attributed to religious beliefs, ismore related to vaccine safe-
ty or other personal beliefs that are shared across a social networkwith-
in a religious congregation. Political, cultural, and historical context
modiﬁes the effect of religion rather than being speciﬁcally tied to theo-
logical beliefs. Our survey ﬁndings – showing varying views within one
religious group – also suggest that different political, cultural, and his-
torical contexts can additionally inﬂuence vaccine opinion.
The results of the hierarchical regression suggest that countries with
higher mean years of schooling are less likely to report positive vaccine
sentiment, however within a country those with some education hold
more positive views on vaccine importance, effectiveness, and religious
compatibility (thoughmarkedly not safety) than thosewithout. There is
evidence in the recent literature to suggest that more highly educated
elites in the Netherlands (Hak et al., 2005), the United States (Gilkey
et al., 2014; Jones et al., 2010), and Canada (Foty et al., 2010) hold vac-
cine skeptic views, which is in keeping with the highest level of educa-
tion of surveyed respondents (masters/PhD) having the same vaccine
importance sentiment as those with no or little education. Further sys-
tematic reviews have highlighted the variability of correlations found
between education and vaccine conﬁdence, with no clear pattern ex-
cept to show that education does not always imply conﬁdence (Brown
et al., 2010; Larson et al., 2014a, 2014b). Other individuals with low in-
come and the unemployed also exhibit less positive vaccine views.
The results of this study provide valuable insights on public opinion
of vaccines which can help enable policymakers and stakeholders to
identify countries of particular concern with respect to the four sur-
veyed areas of vaccinehesitancy. This study canhence be used as a base-
line with which to compare future surveys on vaccine hesitancy (thus
monitoring the evolution of vaccine-hesitancy) and with which future
surveys can be tailored to identify hesitancies toward particular vacci-
nations and investigate local drivers of hesitancy. The ﬁndings herein,
coupled with the recent literature on vaccine conﬁdence, point to theimportance of continued worldwide monitoring of conﬁdence in vac-
cines, so that policymakers canmonitor the effects of their interventions
on immunization attitudes and acceptance andmore effectively allocate
resources to address hesitancy issues and build conﬁdence.
A limitation of this survey is its generality of the survey which does
not reveal whether the attitudes are related to speciﬁc vaccine(s)
which an individual may have concerns about. A study of repeated sur-
veys of vaccination attitudes in France (Peretti-Watel et al., 2013) also
considers general vaccine-skepticism, ﬁnding a link between children
unvaccinated against MMR and unfavorable attitudes towards vaccines
as a whole. The ability to investigate the effect of skepticism towards a
particular vaccine on other vaccines and would help understand how
skepticism towards a particular vaccine can drive other harmful vacci-
nation behaviors. To address these issues, we propose an extension to
the ﬁve-point Likert scale questions to include statements on immuni-
zation intent for speciﬁc vaccines.
A further limitation is the inability in the present study to track
temporal changes of immunization attitude. Repeated surveys allow
for a better understanding of the complex interplay between socio-
economic, political, and religious characteristics, vaccine sentiment,
immunization intent, and immunization rates (de Figeiredo et al.,
2016). Monitoring systems can be developed to track conﬁdence,
forecast areas of concern, and lessen hesitancy through targeted
intervention.
We believe this research has far-reaching public health implica-
tions, and is particularly important in light of the variable progress
in reaching the Millennium Development Goals and implications
for moving forward in the context of new Sustainable Development
Goals. The interconnectivity of vaccine conﬁdence, conﬁdence in
the health system, public trust in government more broadly, and
socio-economic status alongside the inﬂuences of religious and
philosophical beliefs, suggest that measuring vaccine conﬁdence
can be a valuable window on bigger issues at play in the evolving
health and development landscape.
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